Safety and efficacy of rapid withdrawal of anti-seizure medication during long-term video-EEG monitoring - PubMed
- ️Sun Jan 01 2023
Safety and efficacy of rapid withdrawal of anti-seizure medication during long-term video-EEG monitoring
Jiao Liu et al. Front Neurol. 2023.
Abstract
Objective: Anti-seizure medications (ASMs) are often withdrawn during long-term video-EEG monitoring (LTM) to allow pre-surgical evaluation. Herein, we evaluated the safety and efficacy of ultra-rapid withdrawal (URW) and rapid withdrawal (RW) of ASMs in an epilepsy monitoring unit (EMU).
Methods: This retrospective study examined all consecutive patients admitted to our EMU between May 2021 and October 2022. Patients were classified into the URW and RW groups according to the way ASMs were withdrawn. We compared the efficacy and safety of the procedures used in the groups in terms of duration of LTM, latency to the first seizure, and incidence of focal to bilateral tonic-clonic seizures (FBTCS), seizure clusters (SC), and status epilepticus (SE).
Results: Overall, 110 patients (38 women) were included. The mean age of patients at the time of LTM was 29 years. All medications were stopped on admission for monitoring in the URW group (n = 75), while in the RW group (n = 35) ASMs were withdrawn within 1 day. In both groups, the duration of LTM was approximately 3 days: URW group (2.9 ± 0.5 days) and RW group (3.1 ± 0.8 days). The latency to the first seizure was significantly different between the two groups; however, there were no differences between the two groups in terms of the distribution of FBTCS, SC, or SE, number of seizures, and the requirement for intravenous rescue medication was low.
Conclusion: The rapid withdrawal of ASMs to provoke seizures during monitoring for pre-surgical evaluation following the URW protocol was as effective and safe as with RW. Ultra-rapid ASM withdrawal has the benefits of reducing LTM duration and shortening the time to first seizure compared to rapid medication tapering.
Keywords: anti-seizure medication; epilepsy; long-term video-EEG monitoring; pre-surgical evaluation; rapid withdrawal.
Copyright © 2023 Liu, Chen, Xu, Zhang and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

ASMs taken on admission in the URW and RW groups. (A) The type of ASMs in the URW group. (B) The type of ASMs in the RW group. CBZ (carbamazepine), CNP (clonazepam), LCM(Lacosamide), LEV (levetiracetam), LTG (lamotrigine), OXC (oxcarbazepine), PB (Phenobarbital), PER(Perampanel), TPM (topiramate), VPA (valproic acid), ZNS (zonisamide).

Results of seizures occurring before and during the LTM. (A) Percentage patients with FBTCS before and during the LTM. (B) Percentage patients with SC before and during the LTM.
Similar articles
-
Malgireddy K, Gupta N, Baang HY, Samson KK, Madhavan D, Puccioni M, Taraschenko O. Malgireddy K, et al. Epilepsy Res. 2021 Nov;177:106756. doi: 10.1016/j.eplepsyres.2021.106756. Epub 2021 Sep 13. Epilepsy Res. 2021. PMID: 34543831
-
Hampel KG, Morata-Martínez C, Garcés-Sánchez M, Villanueva V. Hampel KG, et al. Seizure. 2024 Feb;115:100-108. doi: 10.1016/j.seizure.2023.12.010. Epub 2023 Dec 16. Seizure. 2024. PMID: 38158320
-
Wang S, Wang W, Yu G, Wan L, Fan Y, Wang H, Liu T, Ji T, Liu Q, Cai L, Liu X. Wang S, et al. Epilepsia Open. 2023 Jun;8(2):313-319. doi: 10.1002/epi4.12680. Epub 2023 Feb 17. Epilepsia Open. 2023. PMID: 36650667 Free PMC article.
-
Cutillo G, Tolba H, Hirsch LJ. Cutillo G, et al. Epilepsy Behav. 2021 Apr;117:107815. doi: 10.1016/j.yebeh.2021.107815. Epub 2021 Feb 26. Epilepsy Behav. 2021. PMID: 33640562 Review.
-
Rapid versus slow withdrawal of antiepileptic drugs.
Ayuga Loro F, Gisbert Tijeras E, Brigo F. Ayuga Loro F, et al. Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD005003. doi: 10.1002/14651858.CD005003.pub4. Cochrane Database Syst Rev. 2022. PMID: 35005782 Free PMC article. Review.
References
Grants and funding
This study was funded by grant 2019HXFH048 from the Clinical Research Incubation Project, West China Hospital, Sichuan University, and grant 2021YFS0174 from the Science and Technology Department of Sichuan Province.
LinkOut - more resources
Full Text Sources